Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage oncology company developing treatments for cancers with critical unmet medical need.

playing cards
Biotech

Oncternal stock sinks 60% amid layoffs, trial terminations

Oncternal is folding all clinical trials and laying off staff, turning its energy toward exploring alternatives such as asset sales or an acquisition.
Gabrielle Masson Sep 12, 2024 10:51am
Red blood cells

Oncternal reports patient death in CAR-T dose-escalation study

Dec 28, 2023 10:52am
dominoes fall stop fail investigation

Facing a crowded market for BTK inhibitors, Oncternal bows out

Apr 4, 2023 4:00am